The biological evaluation of ADMA/SDMA and eNOS in patients with ACHF

Frontiers in Bioscience - Elite

Volumn 5 E, Issue 2, 2013, Pages 551-557

  Speranza, Lorenza ^a   Pesce, Mirko ^a   Franceschelli, Sara ^a   Bucciarelli, Tonino ^a   Gallina, Sabina ^b   Riccioni, Graziano ^c   Patruno, Antonia ^a   Felaco, Mario ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Cardiology Department SS Annunziata Hospital   (Italy)

^c SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

Author keywords

Acute heart failure; ADMA; ENOS; NO; SDMA

Indexed keywords

6 N,N' DIMETHYLARGININE; ALANINE AMINOTRANSFERASE; ARGININE; ASPARTATE AMINOTRANSFERASE; CYTOCHROME C OXIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G),N(G) DIMETHYLARGININE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DRUG DERIVATIVE; N,N DIMETHYLARGININE; N,N' DIMETHYLARGININE; N,N'-DIMETHYLARGININE; N,N-DIMETHYLARGININE; OXYGEN;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART FUNCTION; HUMAN; HUMAN CELL; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; BLOOD; CLINICAL TRIAL; ECHOCARDIOGRAPHY; HEART FAILURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; WESTERN BLOTTING;

ADULT; AGED; ALANINE TRANSAMINASE; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARGININE; ASPARTATE AMINOTRANSFERASES; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIGOXIN; DIURETICS; ECHOCARDIOGRAPHY; ELECTRON TRANSPORT COMPLEX IV; FEMALE; HEART FAILURE; HUMANS; KIDNEY FUNCTION TESTS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; OXYGEN;

MLCS; MLOWN;

EID: 84878488930     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e637     Document Type: Article

References (29)

1. D Tousoulis, M Koutsogiannis, N Papageorgiou, G Siasos, C Antoniades, E Tsiamis, C Stefanadis: Endothelial dysfunction: potential clinical implications. Minerva Med 101, 271-284 (2010)
2. L Speranza, S Franceschelli, M Pesce, M Reale, L Menghini, I Vinciguerra, MA DeLutiis, M Felaco, A Grilli: Anti-inflammatory effects in THP-1 cells treate with verbascoside. Phytother Res 24, 1398-1404 (2010)
3. K Krzyzanowska, F Mittermayer, M Wolzt, G Schernthaner: Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Diabetes Care 30, 1834-1839 (2007)
4. A Meinitzer, U Seelhorst, B Wellnitz, G Halwachs-Baumann, BO Boehm, BR Winkelmann, W Marz: Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem 53, 273-283 (2007)
5. RH Boger: The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovascular Research 59, 824-833 (2003)
6. G Riccioni, V Bucciarelli, L Scotti, A Aceto, N D'Orazio, E Di Ilio, T Bucciarelli: Relationship between asymmetric dimethylarginine and asymptomatic carotid atherosclerosis. J Biol Regul Homeost Agents 24, 351-358 (2010)
7. C Zoccali, F Mallamaci, G Tripepi: Asymmetric dimethylarginine (ADMA) as a cardiovascular risk factor in end-stage renal disease (ESRD). Eur J Clin Pharmacol 62, 131-135 (2006)
8. C Duckelmann, F Mittermayer, DG Haider, J Altenberger, J Eichinger, M Wolzt: Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure. Arterioscler Thromb Vasc Biol 27, 2037-2042 (2007)
9. M Félétou, PM Vanhoutte: Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291, 985-1002 (2006)
10. T Nicholson, T Chen, S Richard: The role of protein arginine methylation in normal and diseased cells. Pharmacol Res 60, 466-474 (2009)
11. P Vallance, J Leiper: Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24, 1023-1030 (2004)
12. SA Hunt, WT Abraham, MH Chin, AM Feldman, GS Francis, TG Ganiats et al.: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112, 154-235 (2005)
13. D Lloyd-Jones, R Adams, M Carnethon, G De Simone, TB Ferguson, K Flegal, E Ford, K Furie, A Go, K Greenlund, N Haase, S Hailpern, M Ho, V Howard, B Kissela, S Kittner, D Lackland, L Lisabeth, A Marelli, M McDermott, J Meigs, D Mozaffarian, G Nichol, C O'Donnell, V Roger, W Rosamond, R Sacco, P Sorlie, R Stafford, J Steinberger, T Thom, S Wasserthiel-Smoller, N Wong, J Wylie-Rosett, Y Hong American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, 480-48 (2009)
14. SA Hunt, WT Abraham, MH Chin, AM Feldman, GS Francis, TG Ganiats, M Jessup, MA Konstam, DM Mancini, K Michl, JA Oates, PS Rahko, MA Silver, LW Stevenson, CW Yanc: Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53, 1-90 (2009)
15. M Saitoh, T Osanai, T Kamada, T Matsunaga, H Ishizaka, H Hanada, K Okumura: High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level. Heart Vessels 18, 177-182 (2003)
16. M Usui, H Matsuoka, H Miyazaki, S Ueda, S Okuda, T Imaizumi: Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 62, 2425-2430 (1998)
17. A. Grilli, MA De Lutiis, A Patruno, L Speranza, F Gizzi, AA Taccardi, P Di Napoli, R De Caterina, P Conti, M Felaco, Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. Ann Clin Lab Sci 33, 208-21 (2003)
18. A Patruno, L Speranza, S Tetè, F Mastrangelo, MA De Lutiis, M Pesce, S Franceschelli, I Vinciguerra, M Felaco, A Grilli: iNOS activity in the aged rat liver tissue. J Biol Regul Homeost Agents 21, 89-95 (2007)
19. MP Pritchard, R Ossetian, DN Li, CJ Henderson, B Burchell, CR Wolf, T Friedberg: A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1. Arch Biochem Biophys 345, 342-354 (1997)
20. Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119, 1977-2016 (2009)
21. TC Lee, JG Hanlon, J Ben-David, GL Booth, WJ Cantor, PW Connelly, SW Hwang: Risk factors for cardiovascular disease in homeless adults. Circulation 111, 2629-2635 (2005)
22. NS Bryan, K Bian, F Murad: Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci 14, 1-18 (2009)
23. H Masuda, T Tsujii, T Okuno, K Kihara, M Goto, H Azuma: Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia. Am J Physiol Regul Integr Comp Physiol 282, 1730-1738 (2002)
24. Y Oner-Iyidogan, P Oner, H Kocak, F Gurdol, S Bekpinar, Y Unlucerci, Y Caliskan, P Cetinalp-Demircan, T Kocak, A Turkmen: Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis. Clin Exp Med 9, 235-241 (2009)
25. EI Closs, FZ Basha, A Habermeier, U Forstermann: Interference of L-arginine analogues with L-arginine transport mediated by the carrier hCAT-2B. Nitric Oxide 1, 65-73 (1997)
26. E Schepers, G Glorieux, A Dhondt, L Leybaert, R Vanholder: Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transplant 24, 1429-1435 (2009)
27. JT Kielstein, SR Salpeter, SM Bode-Boeger, JP Cooke, D Fliser: Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-a Metaanalysis. Nephrol Dial Transplant 21, 2446-2451 (2006)
28. JS Beckman, WH Koppenol: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271, 1424-1437 (1996)
29. GL Squadrito, WA Pryor: Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 25, 392-403 (1998)